Navigation Links
La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial

Data Support Ability of Higher Doses to Further Reduce Antibodies to Double-Stranded DNA

SAN DIEGO, March 08, 2007 /PRNewswire-FirstCall/ -- La Jolla Pharmaceutical Company today announced positive interim antibody results from its ongoing double-blind, placebo-controlled randomized Phase 3 trial of Riquent(R) (abetimus sodium), its drug candidate for systemic lupus erythematosus ("lupus" or "SLE"). Analyses of interim antibody data indicate that patients treated with 900 mg or 300 mg per week doses of Riquent had greater reductions in antibodies to double-stranded DNA (dsDNA) than patients treated with 100 mg per week or placebo. The results showed a significant dose response when comparing all Riquent-treated patients to placebo-treated patients (p < 0.0001), and each Riquent dose group to the placebo dose group (p < 0.0015 for 100 mg, p < 0.0001 for 300 mg and 900 mg).

"We are very excited by these results. The higher the dose, the greater the reduction in antibodies to dsDNA, and the relative magnitude of these reductions is greater than we have seen in previous studies, which used lower doses of Riquent. Higher doses also appear to result in a larger percentage of patients having greater and more consistent antibody reductions over time," said Deirdre Y. Gillespie, M.D., President and CEO of La Jolla Pharmaceutical Company. "In addition, preliminary assessment of the data indicates that Riquent is being as well tolerated at all doses in the ongoing Phase 3 study as in our previous studies. We believe that the greater reductions in antibodies to dsDNA observed with these higher doses of Riquent imply a greater probability of obtaining positive clinical results from the Phase 3 trial."

"These data definitely show an increased biological effect. This will improve the likelihood of detecting clinical effects of the treatment," said Joan Merrill, M.D. of the Oklahoma Medical Research Foundation. "
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:5/5/2015)... LITTLETON, Mass. , May 5, 2015  Image ... announces a new agreement with MedAssets, one of the ... hospitals in the United States.  Under terms of the ... products, accessories, and services will be made available to ... In announcing the partnership, Image Stream Medical CEO ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory,Molecular Diagnostics and Genomic Testing Services ... Asia Pacific Version" report to their offering. ... growing. Clinical laboratory testing is positioned to directly ... A range of dynamic trends are pushing market ...
(Date:5/5/2015)... BOULDER, Colo. , May 5, 2015  As cannabis prohibition ends one state at a time, more cannabis entrepreneurs are ... past the idea phase, and the primary reason is lack of funding. ... ... ... ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4
... was associated with fewer missed work days and less impairment ... - Final Albuferon Phase 2b quality-of-life data presented at the Annual,Meeting of the ... ... -, ROCKVILLE, Md., Nov. 5 Human Genome ...
... Nov. 2 /PRNewswire/,-- Fabre-Kramer Pharmaceuticals Inc. (FKP) and ... U.S. Food and Drug Administration (FDA) has issued,a ... for gepirone extended-,release (ER) tablets, submitted for the ... FDA had previously reviewed Phase I through III ...
Cached Medicine Technology:Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 2Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 3Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 4Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 5Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 6Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 7Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2
(Date:5/5/2015)... 05, 2015 Information Innovators ... serving the federal government, today announced its acquisition ... CCSi provides solutions exclusively to federal government customers ... in cyber security, health services, and program management ... industry-relevant credentials as a Third Party Assessment Organization ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 On May, 5, ... with Charleston musician Irene Rose about alternatives for youngsters to ... “How did you get the idea for starting a summer ... “I run an entertainment company called Once Upon a Party ... moral lessons through songs and even scripture. We play games, ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 RF Technologies®, ... created the Sensatec® ST750 Fall Management Solution with Voice ... the monitored patient or resident to wait for assistance ... also have the choice of 16 different melodies or ... nurse call system such as Code Alert®. , ...
(Date:5/5/2015)... Major League Ultimate (MLU) was founded by ... Frisbee™ is home to many amazing athletes, dramatic moments, ... world. Nike Ultimate Camps’ goal of spreading the sport ... athletes to learn about the sport and develop their ... , The Nike Ultimate Camp in Philadelphia by MLU ...
(Date:5/5/2015)... 2015 NovaSom, Inc., announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... This segment will focus on NovaSom, a leader in ... about their AccuSom® home sleep test, which is the ... patient support and next-day test results and interpretation. ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2
... gatekeeper leads to the development of arthritis in mice, scientists ... Experimental Medicine . The newly discovered gatekeeper is a protein ... damaging cells that mistakenly attack the body,s own tissues and ... Better understanding how arthritis develops will offer scientists an opportunity ...
... Group, or SWOG, one of the nation,s largest cancer clinical ... in their careers for its 2010 Young Investigator Training Course ... 15 in Seattle, WA for intensive training in how ... this nationally acclaimed program has provided intensive mentorship and career ...
... Researchers in Cedars-Sinai,s Department of Psychiatry and Behavioral ... changes in their body,s immune and endocrine response. ... the health benefits of massage, the Cedars-Sinai study is ... a larger group of healthy adults. ...
... owes as much to art as it does science ... with large scale industry. Confectionery and Chocolate ... of Professor Ferenc Mohos, inside experience to reveal how ... to this unique industry. "Confectionery is usually associated ...
... Reinberg HealthDay Reporter , TUESDAY, Sept. 7 (HealthDay ... 20 percent of Americans still light up, U.S. health officials ... 2000 and 2005, but the decline has leveled out, according ... Control and Prevention (CDC). , "The 40-year decline in tobacco ...
... of the 354 million annual visits for acute care in ... Americans increasingly make busy emergency departments, specialists or outpatient care ... health problems or a flare up of a chronic condition ... in the September edition of Health Affairs , do ...
Cached Medicine News:Health News:Scientists identify molecular gatekeeper of arthritis 2Health News:Scientists identify molecular gatekeeper of arthritis 3Health News:SWOG names 5 cancer researchers outstanding Young Investigators 2Health News:SWOG names 5 cancer researchers outstanding Young Investigators 3Health News:Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show 2Health News:Confectionery and chocolate engineering: Principles and applications 2Health News:Decline in Adult Smoking Stalls, Alarming Experts 2Health News:Decline in Adult Smoking Stalls, Alarming Experts 3Health News:Study finds more Americans bypassing their personal physician when immediate treatment required 2Health News:Study finds more Americans bypassing their personal physician when immediate treatment required 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: